Results 151 to 160 of about 4,983 (214)

Combined oral contraceptives alter ectonucleotidase and adenosine deaminase activities in peripheral blood cells. [PDF]

Purinergic Signal
Moreschi BP, da Silva Portilho R, Santos AN, Brito IL, Otsubo Jaques JA.   +4 more
europepmc   +1 more source

Acute ST elevation myocardial infarction in a young female patient without cardiovascular risk factors-Massive left main coronary artery thrombosis induced by oral contraceptive pills: a case report. [PDF]

J Med Case Rep
Younes S, Jbara R, Rahal M, Seblani M, Zoghbi R, Krayem J, Skhaita Y, Nasser H.   +7 more
europepmc   +1 more source

Non-Invasive Diagnosis of Endometriosis by Questionnaires in Patients Using Contraception. [PDF]

J Clin Med
Zeppernick F, Balimuttajjo S, Schorr C, Sibelius F, Schuler M, Harth S, Seeger S, Löffelmann A, Riaz MA, Meinhold-Heerlein I, Konrad L.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of desogestrel

American Journal of Obstetrics and Gynecology, 1993
A synthetic form of desogestrel, a gonane progestin, was developed because desogestrel's enhanced selectivity eliminates adverse, androgen-dependent, metabolic effects at contraceptive doses. Desogestrel is rapidly and completely metabolized in the liver and gut wall to 3-keto-desogestrel, which is the active metabolite mediating the progestin effects.
Eli Y Adashi
exaly   +3 more sources

Desogestrel

Clinical Obstetrics and Gynecology, 1995
Desogestrel is a new, potent progestogen with very low androgenic properties. When used as a contraceptive, it is a strong antiovulatory compound, even at low doses. The clinical efficacy is as good as that of the old progestogens. It has a low incidence of side effects and complications, similar to other progestogens.
openaire   +2 more sources

Selectivity information on desogestrel

American Journal of Obstetrics and Gynecology, 1993
Improvement in oral contraceptive formulations was originally achieved through dose reduction of the estrogen and progestogen components. Recently, further improvement was achieved by increasing the selectivity of contraceptive progestins. The ratio between the affinity for the progesterone receptor and the affinity for the androgen receptor is an ...
openaire   +2 more sources

Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrel

Contraception, 1986
In a cross-over study with orally administered desogestrel (0.150 mg) plus ethinyloestradiol (0.030 mg) and 3-keto-desogestrel (0.150 mg) plus ethinyloestradiol (0.030 mg) in ten women under steady-state conditions, the serum levels of 3-keto-desogestrel were monitored by radioimmunoassay.
H G, Hasenack, A M, Bosch, K, Käär
openaire   +2 more sources